16
Participants
Start Date
June 13, 2022
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
[U-13C]glucose
\[U-13C\]glucose will be administered as a bolus of 8 g (grams) over 10 minutes followed by 8 g/hour continuous infusion over 2 hours . This infusion rate will allow glucose tracer to reach sufficient enrichment without causing significant metabolic perturbation such as hyperglycemia.
[13C5]glutamine
6mg/kg of body weight of \[13C5\]glutamine will be administered as a bolus over 10 minutes (± 1 minute) followed by 6mg/kg/hr body weight continuous infusion for 2 hours through a peripheral IV catheter/line. This infusion rate will allow glutamine tracer to reach sufficient enrichment without causing significant metabolic perturbation such as hyperglycemia.
RECRUITING
University of Wisconsin, Madison
University of Wisconsin, Madison
OTHER